Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy

SIMPLE SUMMARY: Although sarcopenia-related factors, including decreased skeletal muscle index (SMI), have been reported to affect therapeutic efficacy and the occurrence of adverse events in sorafenib or lenvatinib treatment for hepatocellular carcinoma (HCC), there is considerably less evidence re...

Descripción completa

Detalles Bibliográficos
Autores principales: Oura, Kyoko, Morishita, Asahiro, Manabe, Takushi, Takuma, Kei, Nakahara, Mai, Tadokoro, Tomoko, Fujita, Koji, Mimura, Shima, Tani, Joji, Ono, Masafumi, Ogawa, Chikara, Moriya, Akio, Senoo, Tomonori, Tsutsui, Akemi, Nagano, Takuya, Takaguchi, Koichi, Himoto, Takashi, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296928/
https://www.ncbi.nlm.nih.gov/pubmed/37370853
http://dx.doi.org/10.3390/cancers15123243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296928/
https://www.ncbi.nlm.nih.gov/pubmed/37370853
http://dx.doi.org/10.3390/cancers15123243

Ejemplares similares